CYTR - CytRx Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue100200100
Cost of Revenue---
Gross Profit100200100
Operating Expenses
Research Development19,840.10635,930.21243,395.574
Selling General and Administrative12,502.04215,990.78919,664.904
Non Recurring---
Others629.312536.631317.649
Total Operating Expenses---
Operating Income or Loss-32,871.46-52,257.632-63,278.127
Income from Continuing Operations
Total Other Income/Expenses Net1,717.0394,241.8884,691.737
Earnings Before Interest and Taxes-31,154.421-48,015.744-58,586.39
Interest Expense3,831.2112,754.6772,754.677
Income Before Tax-34,985.632-50,770.421-58,586.39
Income Tax Expense0.80.80.8
Minority Interest---
Net Income From Continuing Ops-34,986.432-50,771.221-58,587.19
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-34,986.432-50,771.221-58,587.19
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-34,986.432-50,771.221-58,587.19